Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactive
Marton Keszei, … , Scott B. Snapper, Lisa S. Westerberg
Marton Keszei, … , Scott B. Snapper, Lisa S. Westerberg
Published August 20, 2018
Citation Information: J Clin Invest. 2018;128(9):4115-4131. https://doi.org/10.1172/JCI64772.
View: Text | PDF
Research Article Immunology

Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactive

  • Text
  • PDF
Abstract

Congenital neutropenia is characterized by low absolute neutrophil numbers in blood, leading to recurrent bacterial infections, and patients often require life-long granulocyte CSF (G-CSF) support. X-linked neutropenia (XLN) is caused by gain-of-function mutations in the actin regulator Wiskott-Aldrich syndrome protein (WASp). To understand the pathophysiology in XLN and the role of WASp in neutrophils, we here examined XLN patients and 2 XLN mouse models. XLN patients had reduced myelopoiesis and extremely low blood neutrophil number. However, their neutrophils had a hyperactive phenotype and were present in normal numbers in XLN patient saliva. Murine XLN neutrophils were hyperactivated, with increased actin dynamics and migration into tissues. We provide molecular evidence that the hyperactivity of XLN neutrophils is caused by WASp in a constitutively open conformation due to contingent phosphorylation of the critical tyrosine-293 and plasma membrane localization. This renders WASp activity less dependent on regulation by PI3K. Our data show that the amplitude of WASp activity inside a cell could be enhanced by cell-surface receptor signaling even in the context in which WASp is already in an active conformation. Moreover, these data categorize XLN as an atypical congenital neutropenia in which constitutive activation of WASp in tissue neutrophils compensates for reduced myelopoiesis.

Authors

Marton Keszei, Julien Record, Joanna S. Kritikou, Hannah Wurzer, Chiara Geyer, Meike Thiemann, Paul Drescher, Hanna Brauner, Laura Köcher, Jaime James, Minghui He, Marisa A.P. Baptista, Carin I.M. Dahlberg, Amlan Biswas, Sonia Lain, David P. Lane, Wenxia Song, Katrin Pütsep, Peter Vandenberghe, Scott B. Snapper, Lisa S. Westerberg

×

Figure 1

Severe neutropenia with hyperactivated neutrophils in the blood of XLN patients.

Options: View larger image (or click on image) Download as PowerPoint
Severe neutropenia with hyperactivated neutrophils in the blood of XLN p...
(A) Forward and side scatter flow cytometry plots of RBC-lysed blood from WASp L270P XLN patients (X1 and X2), their mutation carrier mother (M), their sister with unknown carrier status (S), and 2 healthy male controls (C1 and C2). Granulocyte (Gr), monocyte (Mo), and lymphocyte (Ly) gates are marked with circles. (B) CD15 vs. CD16 staining of whole-blood granulocytes. Eo, eosinophils; Neu, neutrophils. (C and D) Granulocyte and neutrophil numbers in blood counted (from A and B populations) with flow cytometry using counting beads. (E) hCAP18 expression in serum as determined by Western blot. Serum from SCN1 (ELANE) and SCN3 (HAX1) patients served as references. (F) Densitometry of hCAP18 blots indicated as percentage density of 1 μg/ml hCAP18 reference sample. BD, below detection limit. (G) Percentage and number of CD34+ hematopoietic progenitors in the blood of C2, X1, X2, M, and C3 (female control). (H) Composition of in vitro–differentiated myeloid liquid cultures from CD34+ blood cells.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts